Distributed Bio: Deal sees Charles River Labs acquire large-molecule discovery platform
Preclinical contract research organization (CRO), Charles River Laboratories International, has announced the acquisition of an antibody discovery company, Distributed Bio, for US$83m in cash.
Read full article »
Distributed Bio develops a San Francisco-based cloud computational platform that provides antibody repertoire analysis and therapeutic discovery solutions.
Read more